Study of the Effects of an Oral Nitric Oxide Supplement on Blood Pressure in Prehypertensive Adults

Status unconfirmed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Prehypertension

In brief

Oral supplementation of Neo40(TM), a nitrate lozenge, will reduce blood pressure in healthy adults with clinical prehypertension.

Key facts

Study ID

NCT01937754

Run by

Neogenis Laboratories

People needed

30

Starts

2013-01-01

Last updated by the study team

2013-09-10

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults between the ages of 18 to 80 years
• Two blood pressure readings of >/=135/80 mmHg at rest, thus representing prehypertension
• Informed consent

You may not qualify if…

• Existence of any significant internal or cardiovascular disease;
• Current use of any antihypertensive medication.
• Inability to give informed consent, or fill out standard questionnaires or inability to follow up clinically.

Where it is running

• California Medical Institute — Beverly Hills, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.